Caitong International Asset Management’s SBC Medical Group SBC Stock Holding History

Caitong International Asset Management’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12	Buy	+4	New	+$14	﹤0.01%	2620

Other funds holding SBC

Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Caitong International Asset Management's SBC Position: Q2 2026 in Review

Caitong International Asset Management opened a new position in SBC Medical Group (SBC) in Q2 2026: 4 shares worth $12. The stake represents ﹤0.01% of the portfolio and ranks #2620 among its holdings.

57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

Caitong International Asset Management held 4 shares of SBC Medical Group worth $12 as of Q2 2026.
SBC Medical Group was a new Caitong International Asset Management position in Q2 2026.
SBC Medical Group made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #2620 holding.
57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.